Author

Andrea Vanesa Gamarnik

Consejo Nacional de Investigaciones Científicas y TécnicasORCID 0000-0002-9789-4105Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 2 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:multiome· 1 Assay:proteomics· 1

Frequent Co-Authors

Andrés WigdorovitziD· 1 shared Ariel BazziniiD· 1 shared Daniela Bottero· 1 shared Daniela Flavia HozboriD· 1 shared Diego Ezequiel AlvareziD· 1 shared Erika Rudi· 1 shared Eugenia ZuritaiD· 1 shared Horacio M. PallarésiD· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Andrés WigdorovitzORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Molecular BiologyMolecular Systems BiologyPeer-reviewedJul 22, 2024

Dengue virus preferentially uses human and mosquito non-optimal codons

Luciana Andrea Castellano, Ryan J McNamara, Horacio M. Pallarés…·Ariel Bazzini

This study shows that dengue virus uses non-optimal codons in both human and mosquito cells, enhancing its fitness and suggesting synonymous codon choice is critical in host-pathogen interactions.

20 citations

humanmouse

𝕏 PostBluesky

ImmunologyFrontiers in ImmunologyPeer-reviewedNov 10, 2023

Heterologous booster with a novel formulation containing glycosylated trimeric S protein is effective againstOmicron

Daniela Bottero, Erika Rudi, Pablo Martín Aispuro…·Daniela Flavia Hozbor

This study evaluates the effectiveness of heterologous booster vaccines against Omicron BA.1 using a mouse model, showing that mRNA-based vaccines outperform vector-based ones, while heterologous boosters improve immune responses.

DOI 10.3389/fimmu.2023.1271209

mouseproteomics

𝕏 PostBluesky